Beyond their ability to produce antibodies,^[@R1]^ B cells produce proinflammatory or anti-inflammatory cytokines,^[@R2],[@R3]^ present antigen to T cells,^[@R4]^ and regulate B- and T-cell responses.^[@R5]^ Mature naive bone marrow (BM)--derived B-2 cells home into secondary lymphoid organs (SLOs) where they undergo somatic hypermutation and affinity maturation in germinal centers (GCs). Antigen-experienced B-2 cells either become short-lived plasma cells (PCs) residing in SLOs or they develop into long-lived PCs that largely home to the BM.^[@R6]--[@R8]^ By contrast, the majority of B-1 cells are located in the peritoneal cavity (PerC) and pleural cavities where they form a pool of quiescent innate B cells. On migration to inflammatory tissues, B-1 cells become activated and self-renew to carry out T-cell--independent protective immune responses.^[@R9]--[@R12]^ Recent reports showed differential effects of B-cell subsets in atherosclerosis^[@R13]--[@R24]^ with antiatherogenic effects of B-1 cells and proatherogenic effects of B-2 cells.^[@R25]--[@R27]^ In addition to SLOs and the BM, B-cell responses may be organized in artery tertiary lymphoid organs (ATLOs) in apolipoprotein E-deficient (*ApoE*^*−/−*^) mice.^[@R28],[@R29]^ Here, we report on local aorta as opposed to systemic B-cell responses during aging.

Materials and Methods
=====================

Materials and Methods are available in the online-only Data Supplement.

Results
=======

Aorta B-Cell Transcripts During Aging
-------------------------------------

MIAME (minimum information about a microarray experiment)-compliant microarrays were prepared as described^[@R30],[@R31]^; data were deposited in the National Center for Biotechnology Information (<http://www.ncbi.nlm.nih.gov/>) and the gene ontology (<http://www.geneontology.org/>) data banks (accession GSE40156).^[@R30],[@R32]^ To determine if B-cell--related gene expression changes with aging, microarrays of aortas, SLOs, and blood from wild-type (WT) and *ApoE*^*−/−*^ mice were compared. B-cell--related genes were altered in WT aortas during aging (Table I in the online-only Data Supplement). However, there were much more pronounced changes in *ApoE*^*−/−*^ when compared with WT aortas. Expression kinetics of some of these genes correlated with the kinetics of ATLO formation^[@R32],[@R33]^ (Figure [1](#F1){ref-type="fig"}; Table I in the online-only Data Supplement). B-cell transcriptomes contained genes that were expressed exclusively by B cells and a majority of genes that respond to B-cell--derived molecules yielding a complex B-cell immunity--related gene map (Figure [1](#F1){ref-type="fig"}; Table I in the online-only Data Supplement). Examples of the magnitude of B-cell immunity--related transcripts in *ApoE*^*−/−*^ aortas include a 135-fold increase of Ighm (IgM constant region), a 29-fold increase in Ptpn6 (protein tyrosine phosphatase, nonreceptor type 6; SHP1) regulating the IgM repertoire, a 23-fold increase in the immunosuppressive Lilrb3 (leukocyte immunoglobulin-like receptor, subfamily B with transmembrane and immunoreceptor tyrosine-based inhibitory motif domains), Fcer1g (Fc receptor, IgE, high-affinity I, γ-polypeptide), and Cd28 (CD28 antigen) expression that promotes PC survival (Figure [1](#F1){ref-type="fig"}; Table I in the online-only Data Supplement). In contrast, spleen- and blood-transcript maps were considerably smaller, and the extent of differential expression between WT and *ApoE*^*−/−*^ mice was much less pronounced (Figure I in the online-only Data Supplement). The majority of B-cell--associated genes in the spleen and blood were downregulated during aging in both WT and *ApoE*^*−/−*^ mice: Ptprc (B220; Cd45; protein tyrosine phosphatase, receptor type, C) involved in cell fate decisions of the B-cell receptor; Aicda (activation-induced cytidine deaminase) regulating somatic hypermutation and Ig class switching; Sykb (spleen tyrosine kinase) participating in B-memory cell survival; Vav3 (Vav3 oncogene) mediating B-cell receptor responses; Tcf3 (transcription factor 3) controlling B-cell ontogeny; Foxp1 (forkhead box p1) impacting B-cell survival; and Malt1 (Malt1 paracaspase) participating in B-cell malignancies. In summary, the spleen and blood gene maps suggested that age-associated changes largely mirrored B-cell senescence rather than genotype/hyperlipidemia-dependent changes (Figure I and Table I in the online-only Data Supplement).

![Aging-associated changes in aorta B-cell immunity. **A**, Age-associated transcript profiles of wild-type (WT) and *ApoE*^*−/−*^ aorta of 6-, 32-, and 78-week-old mice (3 mice per genotype per age group). Transcripts in gene ontology terms immune system process, B-cell--mediated immunity, B-cell activation, positive regulation of B-cell--mediated immunity, positive regulation of B-cell activation, B-cell proliferation, and B-cell differentiation are displayed as heatmaps. **B**, Expression of selected genes in aorta from WT and *ApoE*^*−/−*^ mice at 6, 32, and 78 weeks; n=3 mice per genotype per age group. Results represent mean±SEM. Analyses were performed using ANOVA with Benjamini--Hochberg correction. Absolute numbers of signal intensities and statistics are reported in Table I in the online-only Data Supplement.](atv-36-1174-g001){#F1}

Transcript Maps Delineate the Territoriality of B-Cell--Related Immune Responses in the Aged *ApoE*^*−/−*^ Aorta
----------------------------------------------------------------------------------------------------------------

Laser capture microdissection aorta-derived tissues were obtained together with renal lymph nodes (RLNs) and spleen.^[@R30],[@R31]^ B-cell--related genes were expressed at higher levels in ATLOs when compared with aorta adventitia segments from WT or *ApoE*^*−/−*^ mice without plaques (Figure [2](#F2){ref-type="fig"}A; Table I in the online-only Data Supplement). In the adventitia cluster, genes associated with B-cell survival, proliferation, differentiation, and activation, such as immunoglobulin genes (ighm), TACI (tnfrsf13b), B-cell activating factor receptor (tnfrsf13c), CD40 antigen (cd40), histocompatibility 2, class II antigen A, β-1 (h2-ab1), complement components (c1qb), and Myd88 (myd88) were robustly expressed in adventitial regions adjacent to plaques compared with adventitia in regions with no plaques (Figure [2](#F2){ref-type="fig"}A; Table I in the online-only Data Supplement). Moreover, the adventitia adjacent to plaques contained transcripts coding for Igj chain (immunoglobulin joining chain; Igj) involved in somatic hypermutation and memory B-cell development; CD79a (immunoglobulin-associated α; Ly54) involved in B-cell receptor signaling; and Ms4a1 (CD20) controlling T-cell--dependent humoral immunity (Figure IIA in the online-only Data Supplement). The plaque--ATLO cluster markedly expressed Cd19 (CD19 antigen) in ATLOs involved in B-cell maturation, Cd20, Igj chain, Igm, and Cd79a/b (Figure [2](#F2){ref-type="fig"}B; Figure IIB in the online-only Data Supplement). In addition, the plaque--ATLO B-cell cluster^[@R30],[@R31]^ showed functional separation in B-cell--related genes in ATLOs versus plaques: bona fide B-cell genes displayed strong expression in ATLOs versus low expression in plaques. For example, Ighm, cd19, ms4a1 (cd20), Igj, and cd79a/b were expressed manifold higher in ATLOs when compared with plaques, which expressed genes that respond to B-cell products (Figure [2](#F2){ref-type="fig"}A; Figure IIB and Table I in the online-only Data Supplement). In contrast, the transcript atlas showed almost identical levels of B-cell--related genes in WT versus *ApoE*^*−/−*^ spleens, RLNs, and blood (Figure I in the online-only Data Supplement; Figure [2](#F2){ref-type="fig"}C and 2D). It is also noticeable that the LN--ATLO cluster shows a comparably higher expression in ATLOs versus LNs of innate immune response genes, such as fcgr1, fcgr2b, fcgr3, c4b, and the c1q family, indicating ongoing inflammation in ATLOs (Figure [2](#F2){ref-type="fig"}C and 2D).

![Aorta transcript maps reveal the specificity and territoriality of B-cell--related immune responses in artery tertiary lymphoid organs (ATLOs). **A**, Heatmaps of differentially expressed genes in the adventitia cluster (wild-type \[WT\], n=3; *ApoE*^*−/−*^, n=4). **B**, Plaque/ATLO cluster (for plaque, n=3; for ATLOs, n=4). **C**, Lymph node (LN) cluster (for WT and *ApoE*^*−/−*^ LNs, n=3; for ATLO, n=4); gene ontology terms immune system process, B-cell activation, B-cell--mediated immunity, immunoglobulin, positive regulation of B-cell--mediated immunity, positive regulation of B-cell activation, B-cell differentiation, and B-cell proliferation. **D**, Selected genes in the LN cluster. Results represent mean±SEM. Analyses were performed using ANOVA with Benjamini--Hochberg correction. Absolute numbers of signal intensities and statistics are reported in Table I in the online-only Data Supplement. RLN indicates renal LNs.](atv-36-1174-g002){#F2}

ATLO B-2 Subtypes Suggest Antigen-Specific GC Reactions
-------------------------------------------------------

B cells present in the aorta of aged *ApoE*^*−/−*^ mice predominantly reside in ATLOs, whereas they cannot be observed in plaques of young WT or *ApoE*^*−/−*^ mice.^[@R30],[@R32],[@R33]^ Fluorescence-activated cell sorting (FACS) analyses of B cells revealed the magnitude of differences in ATLOs and WT adventitia; and B220 immunostaining confirmed that B cells are located in ATLOs and in the adjacent draining LNs but none in WT adventitia or plaques (Figure [3](#F3){ref-type="fig"}A and 3B). Considerable numbers of T-/B-cell clusters referred to as fat-associated lymphoid clusters were observed in paraaortic adipose tissue of aged *ApoE*^*−/−*^ mice and numerous small paraaortic LNs containing B cells lined the tissue adjacent to the adventitia (not shown). There were no differences in the frequency of B cells in SLOs or blood of WT versus *ApoE*^*−/−*^ mice (Figure [3](#F3){ref-type="fig"}C). To obtain evidence for an ongoing GC reaction in ATLOs, CD19, IgM, and IgD antisera together with FACS gating for 4 different populations from CD19^+^ B cells were used (Figure [3](#F3){ref-type="fig"}D). IgM^+^/IgD^−^, IgM^+^/IgD^+^, IgM^−^/IgD^−^, and IgM^−^/IgD^+^ B cells were identified in abdominal but not thoracic aorta segments: IgM^+^/IgD^−^ cells represent either immature or transitional B cells (also referred to as T-1 cells) representing the earliest B-cell stage present outside the BM or these cells may represent B-1 B cells^[@R34]^; IgM^+^/IgD^+^ and IgM^−^/IgD^+^ cells represent mature B-cell stages.^[@R35],[@R36]^ Among mature IgD^+^ cells, IgM^−^/IgD^+^ are mature follicular B-2 cells.^[@R37]^ IgM^−^/IgD^−^ cells represent either switched Ig^+^ B cells, GC B cells that have transiently lost Ig expression when undergoing hypermutation of their Ig genes or GC-derived memory B cells.^[@R34],[@R38]^ None of the subsets were found in the abdominal aorta of WT mice (Figure [3](#F3){ref-type="fig"}D). WT and *ApoE*^*−/−*^ SLOs and blood revealed equivalent numbers of these subsets with the exception of an increase in transitional IgM^+^/IgD^−^ B cells in RLNs of *ApoE*^*−/−*^ versus WT mice (Figure [3](#F3){ref-type="fig"}E). We determined the percentages of IgM^+^/IgD^+^ or switched Ig^+^ B cells in SLOs, blood, WT aortas, and ATLOs. SLO and blood IgM^+^/IgD^+^ and switched Ig^+^ B cells were similar in WT and *ApoE*^*−/−*^ SLOs (Figure [3](#F3){ref-type="fig"}F and 3G). Although undetectable in WT adventitia, the percentage of IgM^+^/IgD^+^ B cells in ATLOs approached that in SLOs (Figure [3](#F3){ref-type="fig"}F). However, the percentage of switched Ig^+^ B cells in ATLOs exceeded those in SLOs or blood (Figure [3](#F3){ref-type="fig"}G). We determined the number of B-1 cells in the PerC and of plasmablasts and PCs in the abdominal aorta, spleen, and RLNs of *ApoE*^*−/−*^ mice (Figure III in the online-only Data Supplement). No change in B-1 B cell subtypes was observed in the PerC of WT versus *ApoE*^*−/−*^ mice (Figure IIIA in the online-only Data Supplement). Moreover, aged *ApoE*^*−/−*^ abdominal aortas, spleens, and RLNs contained plasmablasts and PCs; some of which expressed interleukin (IL)-10 (Figure IIIB in the online-only Data Supplement).

![Artery tertiary lymphoid organs (ATLOs) harbor a diverse repertoire of B-cell subsets. **A**, Flow cytometry of CD19^+^ B cells of total CD45^+^ leukocytes in abdominal aorta of 80-week-old wild-type (WT) and *ApoE*^*−/−*^ mice (WT, n=11; *ApoE*^*−/−*^, n=10). **B**, Immunofluorescence staining with anti-B220 antisera shows B cells in ATLOs and lymph nodes (LNs) but none in the media (M) or plaque (P) or in WT adventitia. **C**, B cells in the spleen, renal LNs (RLNs), and blood of WT and *ApoE*^*−/−*^ mice (WT, n=8; *ApoE*^*−/−*^, n=6). Flow cytometric analysis of IgM^+^IgD^−^, IgM^+^IgD^+^, IgM^−^IgD^−^, and IgM^−^IgD^+^ B cells per total CD19^+^ B cells in abdominal aorta (**D**) and spleen, RLN, and blood of 80-week-old WT and *ApoE*^*−/−*^ mice (WT n=4; *ApoE*^*−/−*^ n=5; **E**). Percentages of IgM^+^IgD^+^ B cells (**F**) and IgM^−^IgD^−^ B cells per total B cells in ATLOs, spleen, RLN, and blood of age-matched WT and *ApoE*^*−/−*^ mice (**G**). Results represent mean±SEM; \**P*\<0.05, \*\**P*\<0.01, and \*\*\**P*\<0.001; 2-sided unpaired Student *t* test. n indicates the number of experiments; n.d., not detectable; ns, not significant; and SSC, side scatter.](atv-36-1174-g003){#F3}

ATLOs Harbor GC B Cells and IgG1^+^, IgA^+^, and IgE^+^ Memory Cells
--------------------------------------------------------------------

Naive B cells in SLOs enter GCs to undergo a GC reaction involving somatic hypermutation and affinity maturation of their B-cell receptors. ATLO GC B cells were identified by FACS (IgD^−^/PNA^+^/GL-7^+^): they were undetectable in WT aortas but ranged at ≈9% of all IgD^−^ B cells in ATLOs (Figure [4](#F4){ref-type="fig"}A and 4B). Their number was similar in WT and *ApoE*^*−/−*^ spleen and blood although they were more abundant in *ApoE*^*−/−*^ when compared with WT RLNs (Figure [4](#F4){ref-type="fig"}B). We sought evidence for isotype-switching using FACS analyses. Surprisingly, we observed significant numbers of CD19^+^/IgD^−^/IgG1^+^, CD19^+^/IgD^−^/IgA^+^, and CD19^+^/IgD^−^/IgE^+^ B cells in ATLOs (Figure [4](#F4){ref-type="fig"}C and 4D). Although class switching is not restricted to GCs, the presence of GCs and cells that class switched to T-dependent Ig subclasses, such as IgG1, suggests that these cells resemble memory B cells. Intriguingly, the percentage of IgD^−^ B cells that class switched to IgG1 was significantly greater than those in the spleen, RLNs, BM, or blood (Figure [4](#F4){ref-type="fig"}D). In contrast, there were equivalent percentages of IgG1^+^ B cells in the spleen, BM, and blood of WT versus *ApoE*^*−/−*^ mice. Consistent with rare ATLO formation in the thoracic aorta,^[@R32]^ no GC B cells or class switched B cells were observed there (not shown). These data provide evidence for a disease-specific antigen-dependent B-2 B cell maturation pathway in ATLOs.

![Artery tertiary lymphoid organs (ATLOs) contain B cells that participate in humoral immune responses. **A**, IgD^−^ B cells gated from CD19^+^ total B cells were evaluated for PNA^+^/GL-7^+^ (germinal center \[GC\] B cells) in ATLOs. **B**, GC B cells in ATLOs and SLOs were quantified (wild-type \[WT\], n=4; *ApoE*^*−/−*^, n=5). **C**, IgG1^+^ (IgG1^+^/CD38^+^), IgA^+^ (IgA^+^/CD38^+^), and IgE^+^ (IgE^+^/CD38^+^) memory B cells were gated from total CD19^+^/IgD^−^ B cells. **D**, Quantification of IgG1^+^, IgA^+^, and IgE^+^ memory B cells in ATLOs, SLOs, blood, and bone marrow (BM; WT, n=4; *ApoE*^*−/−*^, n=4). Results represent mean±SEM; \**P*\<0.05, 2-sided unpaired Student *t* test. **E**, Immunofluorescence data of IgE^+^ memory B cells (IgE^+^/B220^+^ indicated with arrows and IgE^+^/B220^−^ cells indicated with arrow heads), IgA^+^ memory B cells (IgA^+^/B220^+^), long-lived plasma cells (PCs; CD138^+^/BrdU^−^) and short-lived PCs (CD138^+^/BrdU^+^; white arrow), IgM- (IgM^+^/CD138^+^), and IgG1- (IgG1^+^/CD138^+^) producing PCs in ATLOs. Dotted line outlines media. n indicates the number of experiments; n.d., not detectable; ns, not significant; P, plaque, and RLN, renal lymph node.](atv-36-1174-g004){#F4}

Short-Lived and Long-Lived PCs in ATLOs
---------------------------------------

Long-lived PCs are major constituents of humoral memory. Long-lived PCs preferentially home to the BM, whereas short-lived PCs remain within SLOs. Nothing is known about PCs in atherosclerosis. As long-lived PCs survive for long periods of time in the BM,^[@R39]^ we determined the composition of ATLO PC subtypes.^[@R8]^ Both long-lived and short-lived PCs were observed in ATLOs (Figure [4](#F4){ref-type="fig"}E).^[@R40],[@R41]^ Moreover, survival factors for long-lived PCs, including CXCL12, B-cell activating factor,^[@R39]^ and others, are markedly expressed in ATLOs^[@R30],[@R32]^ (Table I in the online-only Data Supplement).

ATLOs Promote B-2 and B-1 Cell Recruitment Into the Arterial Wall
-----------------------------------------------------------------

To determine B-cell recruitment by ATLOs, we adoptively transferred Ly5.1 B-2 cells to aged Ly5.2 WT or *ApoE*^*−/−*^ mice. After 36 hours, B-2 cells had migrated predominantly to the abdominal aorta of *ApoE*^*−/−*^ mice (Figure [5](#F5){ref-type="fig"}A and 5B) although none were recruited to WT aortas. Comparably low but similar numbers of B-2 cells were recruited into the PerCs of WT and *ApoE*^*−/−*^ mice. There was no difference in B-cell recruitment into the spleen, RLNs, and BM of WT versus *ApoE*^*−/−*^ mice (Figure [5](#F5){ref-type="fig"}C). Similar data were obtained with B-1 cells (not shown).

![Artery tertiary lymphoid organs (ATLOs) promote B-2 B-cell recruitment into the abdominal aorta, skewing of ATLO B-1 cells toward B-1b cells. Fluorescence-activated cell sorting (FACS)--purified Ly5.1^+^ CD19^+^/CD43^−^ B-2 cells (purity, \>98%) were adoptively transferred via tail vein injection into aged wild-type (WT) or *ApoE*^*−/−*^ mice. Thirty-six hours later, Ly5.2^+^ recipient mice were analyzed for B-2 cell migration into ATLOs or thoracic aorta segments. **A**, Migrated B-2 B cells were gated from total B cells in ATLOs. **B**, Quantification of migrated Ly5.1^+^ B-2 B cells in aorta. **C**, Peritoneal cavity (PerC), spleen, renal lymph nodes (RLNs), and bone marrow (BM). Results represent mean±SEM; \**P*\<0.05, 2-sided unpaired Student *t* test. WT, n=3; *ApoE*^*−/−*^, n=3. B-1 cells selectively accumulate in ATLOs. **D**, IgM^hi^/CD43^+^ B-1 cells were gated from CD19^+^ B cells, and CD5^+^ B-1a and CD5^−^ B-1b cells were gated from total B-1 cells in ATLOs and the percentage of B-1 cells from total B cells were quantified in ATLOs and SLOs. **E**, Absolute numbers of B-1 cells were quantified in aortic segments in WT and *ApoE*^*−/−*^ mice. The ratio of B-1b/B-1a B cells in ATLOs compared with that in PerC of WT and *ApoE*^*−/−*^ mice. FACS plots show the gating strategy for B-cell subpopulations in PerC (**F**) and their frequencies of B cells in CD45^+^ cells, B-1, and B-2 cells in total B cells, B-1a, and B-1b cells in B-1 cells were compared between WT and *ApoE*^*−/−*^ mice (**G**). Results represent mean±SEM; \*\**P*\<0.01 and \*\*\**P*\<0.001; 2-sided unpaired Student *t* test with Bonferroni--Holm correction. WT and *ApoE*^*−/−*^, n=5--6. n indicates the number of experiments; n.d., not detectable; ns, not significant; and SSC, side scatter.](atv-36-1174-g005){#F5}

B-1 Cells Accumulate in ATLOs and Are Skewed Toward B-1b Cells
--------------------------------------------------------------

B-1 cells are predominantly located in body cavities.^[@R42],[@R43]^ Recent studies showed that B-1a cells reside in the aorta perivascular tissue of young *ApoE*^*−/−*^ mice.^[@R22]^ To determine if B-1 cells are located in the aged aorta adventitia, we performed FACS analyses. A high percentage of all B cells, that is, ≈21%, in ATLOs were B-1 cells (Figure [5](#F5){ref-type="fig"}D), and their relative contribution to all B cells exceeded that in the spleen and RLNs by a large margin (Figure [5](#F5){ref-type="fig"}D). The reason for B-1 B-cell accumulation is most likely the high expression of CXCL13 in ATLOS. Numbers of total B-1 cells in ATLOs are comparable with that of IgM^+^/IgD^−^ cells, indicating that most IgM^+^/IgD^−^ cells found in this compartment are B-1 cells. The abdominal aorta harbored considerably higher numbers of B-1 cells when compared with the thoracic aorta (Figure [5](#F5){ref-type="fig"}E). The B-1 subtype composition was aberrant as we observed a high number of B-1b versus B-1a cells, which dramatically differs from that relation in the PerC (Figure [5](#F5){ref-type="fig"}E).^[@R9]^ There was no significant difference in total B cells, B-2, B-1a, and B-1b cells in the PerC of aged WT and *ApoE*^*−/−*^ mice (Figure [5](#F5){ref-type="fig"}F and 5G).

Majority of ATLO B-1b but Not B-2 Cells Express IL-10, PD-L1, FasL, and Transforming Growth Factor-β
----------------------------------------------------------------------------------------------------

In view of skewing of ATLO B-1 cells toward the B-1b subtype (Figure [5](#F5){ref-type="fig"}D and 5E) and a recent report showing that B-1b cells protect against atherosclerosis,^[@R21]^ we searched for mechanisms of immunosuppression within the arterial wall. IL-10--producing B-1a rather than B-1b or B-2 cells were found in the PerC (Figure IIIA in the online-only Data Supplement). However, we observed that the majority (≈72%) of abdominal aorta B-1b cells produced IL-10 though a minor component of B-1a cells and a significant but low proportion of IL-10^+^ cells in the thoracic aorta (not shown). No or comparably low numbers of B-1a cells or B-2 cells expressed IL-10 (Figure [6](#F6){ref-type="fig"}A). Moreover, the frequency of IL-10^+^ B cells in ATLOs is higher than those of their counterparts in the spleen and RLNs of WT or *ApoE*^*−/−*^ mice (Figure [6](#F6){ref-type="fig"}B). Following a report that a subset of PCs secretes IL-10,^[@R44]^ we assessed IL-10 expression in PCs. A significant proportion of ATLO CD138^+^/CD19^+^ plasmablasts were IL-10^+^ PCs (Figure IIIB in the online-only Data Supplement). Similar PCs have been shown to suppress immune responses in disease models.^[@R45]^ We further assessed the phenotype of B-1 cells in the abdominal aorta. ATLO B-1 but to a much lesser extent B-2 cells expressed PD-L1, FasL, and transforming growth factor-β, indicating that these cells exert immunosuppressive functions (Figure [6](#F6){ref-type="fig"}A).

![Artery tertiary lymphoid organ (ATLO) B-1 B cells show a predominant immunosuppressive IL-10^+^/PD-L1^+^/FasL^+^/TGFβ^+^ phenotype. Cell suspensions from individual aged *ApoE*^*−/−*^ mice. **A**, IL-10^+^, TGFβ^+^, PD-L1^+^, and FasL^+^ abdominal aorta B cells. **B**, *ApoE*^*−/−*^ (red) spleen (80- to 85-week old mice) and WT (blue); *ApoE*^*−/−*^ (n=3--4). B-1a, B-1b, and B-2 cell populations were gated and assayed for cytokine expression (or isotype control, black). Numbers designate frequencies of positive cells.](atv-36-1174-g006){#F6}

Ig-Secreting Cells Accumulate in ATLOs
--------------------------------------

ELISPOT (enzyme-linked immunospot) experiments were performed. There were no constitutively IgM- and IgG-secreting cells in either the thoracic or abdominal aorta of WT mice (Figure [7](#F7){ref-type="fig"}A and 7B). Few IgM- and IgG-secreting cells were observed in the thoracic aorta of *ApoE*^*−/−*^ mice (Figure [7](#F7){ref-type="fig"}A and 7B). However, ATLOs contained abundant IgM- and IgG-secreting cells amounting to ≤80-fold increase of IgM-secreting B cells and a 24-fold increase in IgG-secreting B cells in the abdominal aorta (Figure [7](#F7){ref-type="fig"}A and 7B). Blood contains few (\<10 cells per 0.5 mL of blood) IgM- or IgG-secreting cells (data not shown). In the spleen and RLNs, there was no difference in Ig-secreting cells between WT and *ApoE*^*−/−*^ mice (Figure [7](#F7){ref-type="fig"}C). However, IgM-secreting cells were higher in *ApoE*^*−/−*^ BM when compared with WT BM raising the possibility of a systemic PC response in *ApoE*^*−/−*^ mice. To examine a systemic B-cell response, we determined serum titers of IgM, IgG, and IgE, as well as anti--malondialdehyde-modified low-density lipoprotein (MDA-LDL) IgM and IgG. Aged *ApoE*^*−/−*^ mice had significantly higher levels of total IgM but not IgG or IgE levels when compared with aged WT mice (Figure [7](#F7){ref-type="fig"}D). Although anti--MDA-LDL IgM levels were not different, anti--MDA-LDL IgG levels were significantly higher in *ApoE*^*−/−*^ versus WT mice (Figure [7](#F7){ref-type="fig"}E).

![IgM- and IgG-secreting B cells are selectively located in artery tertiary lymphoid organs (ATLOs). **A**, ELISPOT (enzyme-linked immunospot) analyses of IgM- and IgG-secreting B cells in ATLOs and thoracic aorta segments. **B**, Quantification of IgM- and IgG-secreting cells in ATLOs versus thoracic aorta. **C**, Quantification of IgM-secreting cells in the spleen, renal lymph node (RLN) and bone marrow (BM) of age-matched wild-type (WT) and *ApoE*^*−/−*^ mice. **D**, Serum titers of IgM, IgG, and IgE in aged WT and *ApoE*^*−/−*^ mice. **E**, Anti--MDA-LDL IgM and anti--malondialdehyde-modified low-density lipoprotein (MDA-LDL) IgG serum titers (dilution factor 10 and 25, respectively) in aged WT and *ApoE*^*−/−*^ mice. Results represent mean±SEM; 2-sided unpaired Student *t* test; n=10 per genotype; \**P*\<0.05 and \*\**P*\<0.01. ns indicates not significant.](atv-36-1174-g007){#F7}

Discussion
==========

These data identify ATLOs as the principal lymphoid tissue that orchestrates atherosclerosis B-cell immunity during aging of *ApoE*^*−/−*^ mice. Atherosclerosis ATLO B-cell responses are specific, robust, highly territorialized, multilayered, and include a comprehensive adaptive B-2 and a substantial aberrant innate B-1 cell component: ATLOs but not WT adventitia harbor an unusual set of class-switched IgG1^+^, IgA^+^, and IgE^+^ B cells, a significant number of IL-10^+^/PD-L1^+^/FasL^+^/TGFβ^+^ B-1b cells, and both short-lived and long-lived PCs, including a fraction of IL-10^+^ PCs. This body of data---together with our previous observation that B cells are major constituents of ATLO antigen-presenting cells^[@R30]^---reveal a yet unrecognized scenario of aorta atherosclerosis-specific B-cell immunity, which includes B effector cells, PCs, and several immunosuppressive B-cell subtypes (Figure IV in the online-only Data Supplement).

ATLO B-2 B-cell subtypes include transitional, follicular, GC, and IgG1^+^, IgA^+^, and IgE^+^ B cells---the latter representing class-switched B cells and PCs. These data are the first to suggest that (auto)antigen-dependent hypermutation, proliferation, affinity maturation, Ig class switching, memory cell generation, and differentiation into long-lived PCs may be carried out in the arterial wall. It is becoming evident that ATLOs provide a new paradigm of atherosclerosis-specific B-cell immunity and possibly autoimmunity: ATLO B-cell responses occur in aged animals, whereas aortas of young *ApoE*^*−/−*^ or young and aged WT mice do not show a significant aorta B-cell compartment.^[@R30],[@R46]--[@R48]^ It should be pointed out, however, that this study falls short of proving antigen-specific ATLO-dependent autoimmune B-2 B-cell generation. In this regard, the observation of a considerable number of PCs in ATLOs deserves special attention: PCs may arise from B-1 cells, from B-2 cells via T-cell--independent mechanisms, or from B-2 cells via T-cell--dependent mechanisms.^[@R49]^ Further studies on the origin of aorta PCs seem warranted as the role of PCs in atherosclerosis remains unknown.

Our data demonstrate that local B-cell immune subsets can be distinguished from those in SLOs, the PerC, and the BM: their aberrant nature manifests itself by the presence of large numbers of IL-10^+^ B-1b cells, of short-lived and long-lived PCs, and of IL-10^+^ PCs. Possibly, our aged mice will allow to isolate B cells from ATLOs and SLOs to compare their B-cell receptor repertoire. Moreover, the accumulation of IgA^+^ and IgE^+^ B cells in the diseased aorta indicates links of atherosclerosis B-cell immunity to innate inflammatory leukocytes in plaques. IgA, IgE, and IgG act through either activating or inhibitory Fc receptors on virtually all innate immune cells, including macrophages.^[@R50]^ The expression of divergent Fc receptors raises the possibility that Fc receptors may be involved in the dichotomic control of inflammation within diseased arteries: Fcer1g (Cd23) is a high-affinity IgE receptor that is upregulated during aging, and Fcgr1 (Cd64), Fcgr2b (Cd32), and Fcgr3 (Cd16) are prominently expressed in ATLOs.

ATLOs contain multiple B-cell subtypes, including IgM^+^/IgD^−^, IgM^+^/IgD^+^, IgM^-^/IgD^−^, and IgM^−^/IgD^+^ B cells. ATLO IgM^+^/IgD^−^ and IgM^+^/CD43^+^ B cells may be B-1 cells. In addition, the presence of class-switched memory B cells suggests that some ATLO IgM^+^/IgD^−^ B cells may represent IgM^+^ memory B cells that have not undergone class switching. IgM^+^ memory B cells considerably contribute to the total population of all memory B cells.^[@R51]^ Whether the population of IgM^+^/IgD^−^ B cells within ATLOs also includes a fraction of immature or transitional B cells that represent the earliest B-cell stages that are found outside the BM is a possibility that deserves attention. Under physiological conditions, immature B cells immigrate from the BM and specifically home to splenic follicles to undergo differentiation into a transitional B-cell stage and finally either become mature B-2 or marginal zone B cells.^[@R52]^ This final B-cell maturation is accompanied by a shift of the B-cell receptor repertoire that includes counterselection against autoreactive cells that occurs in discrete and tightly controlled steps.^[@R53]^ Hence, it is tempting to speculate that immature B cells home to ATLOs to undergo differentiation into mature B cells in the absence of the proper control mechanisms acting in the spleen: this could allow for the generation of autoreactive atherosclerosis-specific B cells.
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Highlights
==========

-   Artery tertiary lymphoid organs (ATLOs) orchestrate B-cell responses in the diseased aorta.

-   ATLOs promote B-1 and B-2 cell recruitment into the arterial wall.

-   ATLOs contain germinal center B cells and both short-lived and long-lived plasma cells.

-   ATLOs harbor an aberrant set of B-1 cells whose subtype is skewed toward B-1b cells.

-   A fraction of ATLO B cells produce IgM or IgG.
